Introduction
Conventionally, osteoarthritis (OA) is considered as progressive wear and tear of articular cartilage. However, recent evidence has suggested that it is an inflammatory disease of the entire synovial joint, comprising not only mechanical degeneration of articular cartilage but also concomitant structural and functional change of the entire joint, including the synovium, meniscus (in the knee), periarticular ligament, and subchondral bone. 1 Knee osteoarthritis (KOA) is one of the most common degenerative diseases that causes disability in elderly people. An epidemiological study by Felson et al 2 showed that about 30% of all adults have radiological signs of OA; 8.9% of the adult population has clinically significant OA of the knee or hip, of which KOA was the most common type. Another study also showed that the likelihood of OA increases with age. 3 The Chinese population has a similar prevalence rate. A nationwide populationbased study in China showed an 8.1% total incidence rate of symptomatic KOA and increasing prevalence of KOA with age. 4 A study in Hong Kong showed that 7% of men and 13% of women had KOA. 5 It is estimated that the percentage of older adults in the Hong Kong population will increase from 16.6% in 2016 to 31.1% by 2036. 6 Although clinical guidelines for managing lower limb osteoarthritis (LLOA) in the primary comparison with recently updated international guidelines shows some differences from management in Hong Kong. In ageing populations, such as that in Hong Kong, the prevalence of OA is expected to increase. Therefore, it is of paramount importance to keep updating OA management guidelines so as to provide the best possible evidence-based management in the primary setting. This may help to delay progression into end-stage OA and thus decrease the need for arthroplasty and alleviate long waiting times (the average waiting time for arthroplasty in public hospitals in Hong Kong is 66 months). 5 The aim of the present study was to compare and contrast the LLOA management guidelines proposed in Hong Kong 7 with international guidelines, including the Osteoarthritis Research Society International (OARSI), 8 the American Academy of Orthopedic Surgeons (AAOS), 9 and the American College of Rheumatology (ACR) [ Table 1 ].
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Overview of treatment of knee osteoarthritis
Treatment of KOA can be divided into nonsurgical or surgical treatment. Non-surgical treatment comprises non-pharmacological and pharmacological treatment, and nonpharmacological treatment comprises core first- 
Non-pharmacological treatment of knee osteoarthritis
Education
Both the Hong Kong LLOA and OARSI guidelines aim to teach patients more about OA; provide them with information about the disease process, nature, prognosis, investigation, and treatment options for OA; facilitate changes in health behaviour; and improve compliance with doctor advice. Counselling can take the form of telephone-based or group sessions or spouse-assisted training programmes, and this counselling works in combination with other treatment approaches.
Weight management
The Hong Kong LLOA and other international guidelines agree that weight reduction plays a key role in treating all OA patients. Obesity is strongly associated with an increased risk of developing OA, the requirement of arthroplasty, and physical disability. 11 A meta-analysis reported that obesity increases the risk of developing KOA five-fold, and overweight increases the risk two-fold. 12 The main form of weight management is lifestyle modification, which may include a low-calorie diet, increased physical activity, or anti-obesity drugs; in severe cases, surgery like gastric bypass, adjustable gastric banding, or sleeve gastrectomy should be recommended. Recent studies have proven the significance of weight modification: evidence has shown that knee pain is reduced by over 50% after body weight reduction by around 10%, 13 and weight reduction may drop the risk of developing symptomatic KOA by 50%. 2 It is expected that weight management would also be effective in Hong Kong. A local study investigating the risk factors of KOA showed that overweight was the greatest risk factor for KOA in Hong Kong and that 64% of the investigated Hong Kong patients with KOA were overweight.
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Exercise
Exercise aims to reduce pain and improve general mobility and joint function; more intensive exercise can strengthen the muscle around the knee joint. Exercise is one form of first-line treatment advocated by the Hong Kong LLOA guidelines. There is no recommendation regarding the type of exercise to do, suggesting that it has lower efficacy in reduction of pain and disability compared with weight loss. Exercise is now universally recommended by the other international guidelines. Recent studies suggest the important role of exercise in OA management, and different types of exercise have different benefits in KOA treatment. Targeted strengthening exercises, aerobic exercise, stretching, and flexibility exercises are recommended by AAOS, ACR, and OARSI.
A meta-analysis found that land-based exercise (especially exercise like Tai Chi) has the strongly favourable benefits of improving pain and physical function in patients with KOA; the duration and type of exercise programme in the meta-analyses varied widely, but the general components of the programmes are strength training, active range of motion exercise, and aerobic activity. Although positive results were obtained for land-based exercise, they did not favour any specific exercise regimen or duration. 14 A study in 2016 found that water-based exercise has short-term benefits for function but minor benefits for pain. 15 It is suggested for patients with functional or mobility limitations.
Strength training exercises include primarily resistance-based lower limb and quadriceps strengthening exercises. A meta-analysis in 2011 showed moderate benefits of reducing pain and improving physical function. However, the duration of exercise varied among these programmes. 16 
Biomechanical intervention and walking canes
Biomechanical intervention and walking canes are not included in the Hong Kong LLOA guidelines but are regarded as appropriate and effective by the OARSI guidelines. A literature review suggests that knee braces and foot orthoses could have a positive impact on decreasing pain and stiffness and improving physical function. However, conclusions about their effectiveness have yet to be made because of the lack of clinical trials and the heterogeneity of interventions among the studies reviewed. 17 Both the OARSI and ACR guidelines suggest that walking canes are appropriate for KOA but not appropriate for multi-joint OA because they may increase weight loading on other affected joints. 18 In contrast, the AAOS guidelines are inconclusive about this topic.
Pharmacological treatment of knee osteoarthritis
Paracetamol
The Hong Kong LLOA guidelines stipulate that paracetamol is a key medication for knee OA. It is regarded as the first-line treatment for mild to moderate OA pain because of its efficacy, safety, and cost, and it is also the preferred essential component of long-term pain control. However, it is no longer the first-line treatment suggested by OARSI, as a meta-analysis showed that paracetamol has low efficacy for pain management. 19 The OARSI guidelines recommend that paracetamol be given in conservative doses and durations, as there is concern regarding an increasing risk of gastrointestinal disturbance and multi-organ failure.
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Non-steroidal anti-inflammatory drugs
The Hong Kong LLOA and ACR guidelines suggest NSAIDs as an alternative to paracetamol, whereas the OARSI guidelines suggest NSAIDs as the preferred first-line pharmacological treatment, because systematic reviews have found that NSAIDs are superior to paracetamol for resting and overall pain. 21 Although NSAIDs are recommended in patients without risk, OARSI is reserved in its recommendation for NSAID use in patients with a high risk of co-morbidities. Non-selective NSAIDs have greater associated upper gastrointestinal risks, whereas selective NSAIDs have more cardiovascular side-effects like myocardial infarction; in addition, both selective and non-selective NSAIDs cause sideeffects like hypertension, congestive heart failure, and renal toxicity. The AAOS recommendations about NSAIDs are inconclusive for symptomatic KOA. The Hong Kong LLOA guidelines and all international guidelines strongly suggest that topical NSAIDs (eg, topical diclofenac) be considered as an option for knee-only OA, but their applicability for multiple joint OA is still uncertain. Both topical and oral NSAIDs have similar efficacy and significant benefits over placebo. Topical ones have less gastrointestinal risk but a higher risk of dermatological side-effects. 22 
Intra-articular steroids
The Hong Kong LLOA, ACR, and OARSI guidelines recommend that steroids only be used in acute exacerbations of joint inflammation, as frequent use can result in cartilage or joint damage and increase infection risk. The AAOS recommendation on this topic is inconclusive.
Intra-articular hyaluronic acid
The Hong Kong LLOA guidelines recommend hyaluronic acid for management of KOA for both pain reduction and functional improvement, as it is considered to have effects comparable to those of oral NSAIDs or steroid injections. However, the AAOS and ACR guidelines do not recommend the use of hyaluronic acid because of the lack of data from randomised controlled trials on either its benefits or safety. The OARSI recommendation is also uncertain because of the inconclusive results of recent meta-analyses. A meta-analysis with blinded trials found only small benefits for pain. 23 
Glucosamine
The Hong Kong LLOA guidelines consider glucosamine to have moderate to large effects on pain and disability in LLOA compared with placebo, and it is associated with few side-effects. It is used commonly as an alternative treatment, especially for mild to moderate KOA. However, all the international guidelines strongly recommend against the use of glucosamine because recent randomised controlled trials showed similar effects to placebo, with independent trials showing smaller effects than commercially funded ones. 24 
Opioids
In Hong Kong, opioid analgesics are considered if paracetamol is inadequate and NSAIDs are contraindicated, ineffective, or poorly tolerated. The ACR also suggested that opioids may be an alternative in failed initial therapy. However, with reference to international guidelines for OA management, we should consider the long-term overall usefulness of opioids. Although they have benefits for pain and physical function, compared with those who are not, patients taking opioids have a chance of adverse withdrawal effects that is 4 times higher, and a risk of developing serious side events, including fractures and cardiovascular events, that is 3 times higher. 25 International guidelines provide a similar recommendation, AAOS makes an inconclusive recommendation, and OARSI is uncertain about opioid use because of the increased risk of sideeffects.
Duloxetine
The use of duloxetine is not suggested by the Hong Kong LLOA guidelines or AAOS. However, OARSI and AAOS suggest that co-existing depression and neuropathic pain contribute to the overall pain syndrome, as the pain experienced in OA is multifactorial. A study showed that duloxetine has pain reduction benefits over placebo. 26 Therefore, it is recommended as a potential adjunct to conventional OA treatment for pain reduction. 
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Models of knee osteoarthritis management and comparison
As mentioned above, an increasing number of studies has proven the effectiveness of exercise and physiotherapy on OA management; with the increasing ageing of the population, it would be ideal for Hong Kong to develop a well-established exercise programme for patients with OA as both a nonsurgical treatment and follow-up. There have already been different well-established exercise programmes for non-surgical OA management throughout the world, and they have achieved great outcomes. Successful examples include the Osteoarthritis Chronic Care Program in Australia (OACCP), 28 Better management of patients with OsteoArthritis in Sweden, 29 and Good Life with osteoArthritis in Denmark ( Table 2) . 30 All of these programmes have been proven to improve patients' pain, mobility, physical function, and quality of life. The OACCP has also proven that an exercise programme helps to decrease the demand for arthroplasty; 11% of knee and 4% of hip OA participants who had been waiting for arthroplasty agreed they no longer needed surgery. Different programmes may have minor arrangements targeting their patients, but their content and training duration are generally similar; these programmes consist of education delivered by physiotherapists and sharing from "expert" patients, supported self-management, and supervised neuromuscular exercise sessions of progressive intensity. These programmes usually last at least 3 months with follow-up for 12 months.
Comprehensive Osteoarthritis ManagEment (COME) initiated in 2016 is a pioneering programme for Hong Kong. 31 The COME programme is a multidisciplinary exercise programme for nonsurgical KOA that consists of a 6-week intensive training programme: the components include a 3-hour nurse-led education session, 12 sessions of physiotherapist-supervised exercises; and five to eight sessions of an occupational therapist-led management programme with emphasis on disease coping strategies and fatigue management. After 1 year, patients enrolled in the COME programme reported short-term improvement in Pain SelfEfficacy Questionnaire, Functional Assessment of Chronic Illness Therapy-Fatigue Scale, physical capacity assessed by quadriceps strength, and physical function assessed by one-minute chair test. One-year improvement showed in Patient-Specific Functional Scale, Chinese version of Self-Efficacy of Exercise, and weekly time spent for exercise (Table 3) .
Conclusion
In ageing populations, the prevalence of KOA is expected to increase; thus, there is a need for consensus on non-surgical OA management, so as to improve outcomes for patients with OA and to decrease the burden of arthroplasty. Various exercise programmes for non-surgical OA management have been shown to be effective for improvement of pain, physical function, mobility, and quality of life, and these programmes have even decreased the need and waiting times for arthroplasty. Long-term follow-up of such exercise programmes should be considered to further assess their outcomes.
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